best crypto under a dollar 2021- Top Overview

According to the Islamic Republic of Iran News Agency (IRNA), a senior Russian parliamentarian called for Iran to join the Ji 'an organization.Hailiang shares: 325,700 shares of the company were repurchased for the first time. Hailiang shares announced that on December 10, 2024, the company repurchased 325,700 shares through a special account for stock repurchase, accounting for 0.0163% of the company's total share capital. The highest transaction price was 10.86 yuan/share, the lowest transaction price was 10.52 yuan/share, and the total transaction amount was 3,518,700 yuan. This repurchase conforms to the requirements of the company's repurchase plan and relevant laws and regulations.Molding technology: The transaction amount of selling Jiangsu Bank shares was 226 million yuan. According to the announcement of molding technology, the company sold 25 million shares of Jiangsu Bank through centralized bidding from December 4, 2024 to December 11, 2024, with a transaction amount of 226 million yuan. After the sale, the company also holds 25,000,600 shares of Jiangsu Bank. This transaction is conducive to optimizing the company's asset structure, revitalizing existing assets, improving asset liquidity and efficiency, and meeting the company's capital needs for future development. The sale is expected to have a positive impact on the company's financial position and cash flow.

It is reported that Walgreens Boots Alliance is negotiating to sell itself to a private equity company, which will delist the drugstore chain. The company's share price has been declining for nearly ten years. According to informed sources, Wobolian and Sycamore Partners have been discussing a deal, which may be completed as early as early next year, provided that the negotiations do not break down. It is reported that the market value of Wobolian peaked at more than 100 billion US dollars in 2015, but it has shrunk to about 7.5 billion US dollars since then.The wide currency and weak credit logic may continue, and the upward direction of the market volatility will not change. The Shanghai and Shenzhen 300ETF South (159925) is gaining momentum. On December 11, the Shanghai and Shenzhen 300ETF South (159925) closed down by 0.25%, with a turnover of 75,892,100 yuan. The constituent stocks are mixed. In terms of rising, Midea Group led the rise, and Changjiang Power followed suit. In terms of decline, China Ping An led the decline, while Contemporary Amperex Technology Co., Limited followed. In the news, Contemporary Amperex Technology Co., Limited, the power battery giant, once again announced that it will build a power battery factory overseas, which will also become the company's third battery factory in Europe. Bank of China Securities said that the important meeting at the end of the year is about to land, and the market may face fluctuations caused by the expected landing of policies in the short term, but the tone of monetary policy will not change. The logic of "wide money+weak credit" will continue in the short term. Under the expectation of loose monetary policy, the upward direction of market volatility will not change. According to industry insiders, looking forward to 2025, the allocation of A-share industry can be developed around three main lines: first, the direction of domestic macro-circulation, attaching importance to "duality and innovation", "debt conversion" and new growth points in the consumption field; Second, science and technology are self-reliant: pay attention to artificial intelligence industry, self-controllable, new energy technology, aerospace information technology and data elements; The third is to open wider to the outside world: pay attention to cross-border e-commerce, digital trade, tax exemption and inbound tourism. You can use the Shanghai and Shenzhen 300ETF South (159925) to lay out the core assets with one click.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.

Port-au-Prince Airport in Haiti will resume normal operation. On December 10th, local time, Haitian Aviation Management Committee announced that Toussaint Louvertur International Airport in Port-au-Prince will resume normal operation on the 11th. Toussaint Louverture International Airport, located in Port-au-Prince, Haiti, is the largest airport in the country. In March this year, Haitian gang militants attacked the airport in an attempt to seize control. Since then, the operation of the airport has been blocked, and most airlines have cancelled flights to Haiti. (CCTV News)Brian Sun, Director of the Arms Control Department of the Ministry of Foreign Affairs, met with Zaka, Director of the International Security and Disarmament Department of the Ministry of Foreign Affairs of Indonesia. On December 10, 2024, Brian Sun, Director of the Arms Control Department of the Ministry of Foreign Affairs, met with Zaka, Director of the International Security and Disarmament Department of the Ministry of Foreign Affairs of Indonesia. The two sides exchanged views on the international and regional security situation, non-proliferation export control and other issues.Changhong Meiling: It plans to use its own idle funds not exceeding 6.35 billion yuan to invest in wealth management products. Changhong Meiling announced that in order to improve the efficiency of the company's use of funds, increase the company's cash assets income, and maximize the interests of shareholders, the company and its subsidiaries (excluding Zhongke Meiling Cryogenic Technology Co., Ltd. and its subsidiaries) will use their own idle funds not exceeding 6.35 billion yuan (this amount can be used in a rolling way) to invest and purchase products with high safety, good liquidity and a term of less than one year.